It was reported on November 27, that Michael J Farrell, Chief Executive Officer at ResMed RMD executed a significant insider ...
Shares of ResMed Inc. RMD slipped 0.26% to $249.33 Wednesday, on what proved to be an all-around rough trading session for ...
What Happened: In a Form 4 filing with the U.S. Securities and Exchange Commission on Wednesday, Farrell, Chief Executive Officer at ResMed, acquired stock options for 33,036 shares of RMD. These ...
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) has released an update.Don't Miss our Black Friday ...
ResMed Inc. is downgraded from buy to watchful hold due to valuation concerns, despite strong financial performance and ...
Analyzing ResMed Inc.'s Q1 2025 results, stock performance, and sentiment to determine if further upside or profit taking is ...
With a market cap of $35.8 billion, ResMed Inc. (RMD) is a global leader in the design, manufacturing, and distribution of ...
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) has released an update. Christopher ...
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) has released an update.Don't Miss our Black Friday ...
ResMed shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 78 to 82. Meet the ...
ResMed Inc.(NYSE:RMD)首席执行官Michael J. Farrell最近出售了2,000股公司普通股。这些股票以平均每股249.665美元的价格售出,总计约499,330美元。此次交易后,这些股份由Lisette and Michael Farrell Foundation持有,首席执行官保留对这些股份的处置权。
Shares of ResMed Inc. RMD advanced 2.37% to $249.56 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.30% to 5,987.37 and ...